The expression of cholesterol carrier apolipoprotein E4 (APOE4) and reduced function of the immune receptor triggering receptor expressed on myeloid cells (TREM2) are both associated with a higher risk for developing AD. The gene discussed is TREM2; the disease is Alzheimer disease.